Related references
Note: Only part of the references are listed.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
COVID-19 infection: the perspectives on immune responses
Yufang Shi et al.
CELL DEATH AND DIFFERENTIATION (2020)
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Melissa Bersanelli
IMMUNOTHERAPY (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
COVID-19 and lung cancer: risks, mechanisms and treatment interactions
Alfredo Addeo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study
Edward Gane et al.
JOURNAL OF HEPATOLOGY (2019)
How we treat patients with lung cancer during the SARS-CoV-2 pandemic:primum non nocere
Giuseppe Banna et al.
ESMO OPEN (2019)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer Benefits and Pulmonary Toxicities
Karthik Suresh et al.
CHEST (2018)
Immune checkpoint blockade in infectious diseases
Michelle N. Wykes et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L. Gay et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection
Guruswamy Karnam et al.
PLOS PATHOGENS (2012)
Share Paper
